Matthew Patterson
2015
In 2015, Matthew Patterson earned a total compensation of $1.8M as President, Chief Executive Officer and Director at Audentes Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $101,920 |
|---|---|
| Option Awards | $1,322,186 |
| Salary | $416,000 |
| Total | $1,840,106 |
Patterson received $1.3M in option awards, accounting for 72% of the total pay in 2015.
Patterson also received $101.9K in non-equity incentive plan and $416K in salary.
Rankings
In 2015, Matthew Patterson's compensation ranked 5,065th out of 13,638 executives tracked by ExecPay. In other words, Patterson earned more than 62.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,065 out of 13,638 | 63rd |
Division Manufacturing | 1,867 out of 5,187 | 64th |
Major group Chemicals And Allied Products | 672 out of 1,857 | 64th |
Industry group Drugs | 534 out of 1,531 | 65th |
Industry Biological Products, Except Diagnostic Substances | 89 out of 260 | 66th |
Source: SEC filing on April 27, 2017.